Digging below the bottom lines of ingredients suppliers and brand behemoths. From the impact of the ongoing economic slowdown to the latest in merger and acquisition activity.
When it comes to cognitive health products, women look for emotional ‘brain food’, while men look for caffeine sources, according to a survey of German students.
The discourse around eye health carotenoid meso-zeaxanthin (MZ) has been marred by commercial interests, according to supplement firm OmniActive Health Technologies.
Sustainability is not such an important issue for the supplements industry, because of the relatively low ingredient volumes involved and a difference in industry priorities, Malaysia-based Carotech has said.
Establishing broad acceptance is the greatest challenge facing the sports nutrition segment today, and this hinges on the creation of local mainstream retail channels, according to one analyst.
BASF says it is honing in on its omega-3 business but will sell a recently acquired low-concentration omega-3 facility in Norway as it aims high-end.
The UK Food Standards Agency (FSA) has backtracked on a decision to close its doors on EU novel foods applications after stakeholder unrest at the UK government austerity driven measure. ...
The UK Food Standards Agency is no longer accepting novel food applications, a development one public policy expert says is “alarming”.
Meso-zeaxanthin (MZ) proponent says a French government report on the fraudulent use of meso-zeaxanthin in eye health supplements casts unnecessary doubt on a safe and viable compound. ...
German flavours and aromas specialist Symrise has won the battle for French flavour and ingredients producer Diana, after agreeing a deal that values the firm at €1.3bn.
Cross-border communication must be provided to combat the confusion caused by the 24 subtly different language versions of EU-approved health claims, as well as countless other cultural nuances, according to...
DSM has ended speculation about acquiring Chinese vitamin C supplier Aland by acknowledging it is in talks with the firm, but asserts no deal has been signed.
Nutrition Capital Network (NCN) is setting up shop in Europe this May at Vitafoods in Geneva and is scouting for investment opportunities in the health and wellness sector.
Russia may still hold the lion share of the dietary supplements market in the Commonwealth of Independent States (CIS), but it’s the comparatively more stable Kazakhstan that will lead in...
Swedish probiotic player BioGaia has broadened and strengthened its ties with food manufacturing giant Nestlé by agreeing a deal for clinical research and new product development (NPD), according to the...
French supplier Ingredia has announced its acquisition of bioactive peptides specialist Galactis Pharma.
Romania and Moldova may still be small markets, but Indena says it sees in them what it saw in Poland 20 years ago.
Sanofi-Aventis has said the European Food Safety Authority’s (EFSA) rejection of its application to broaden the already approved sterol-stanols cholesterol lowering claim to powdered supplements won’t affect the company commercially, but...
‘Nutrition and Health’ was the best performing section within BASF’s ‘Performance Products’ division in 2013, posting a 7% gain on 2012 to push through €2bn in sales for the year.
Plant-based nutrition firm Raisio has reported record earnings before interest and taxes (EBIT) of almost €40m in 2013.
A focus on emerging markets has paid off for Swedish probiotics supplier BioGaia with sales and profits up in 2013.
Protein is still the bedrock of sports nutrition says Euromonitor, but non-protein products are expected to grow faster in several important global markets like Australia, Canada and Indonesia.
Symrise has given Swedish probiotic player, Probi’s board and shareholder’s about a month to sell it the remaining 70% it doesn’t own after making a formal bid today.
Mérieux NutriSciences has acquired a Brazilian lab to expand business in Latin America.
Supplements giant Herbalife has won an appeal against a verdict back in 2011 which tarred the firm's recruitment and selling structure as a pyramid scheme.
Leatherhead to invest in research for a Glycaemic Index (GI) health claim, which it plans to eventually present to EFSA.